Transition Metal Dichalcogenide Nanoflowers Rescue Immune Cells from the Cytotoxic Effects of Amyloid Aggregates

过渡金属二硫化物纳米花可拯救免疫细胞免受淀粉样蛋白聚集体的细胞毒性作用

阅读:1

Abstract

Parkinson's disease (PD) is a severe pathology caused by a progressive degeneration of neurons in the substantia nigra pars compacta, hypothalamus, and thalamus. Although etiology of PD remains unclear, accumulating evidence indicates that neurodegenerative effects are triggered by the abrupt aggregation of α-synuclein (α-Syn), a small membrane protein that is responsible for cell vesicle trafficking. α-Syn aggregates are highly toxic to neurons and immune cells present in the brain, including macrophages, microglia, and dendritic cells. Transition metal dichalcogenide nanoflowers (TMD NFs) are novel nanomaterials with unique optical and biological properties. However, their effects on the immune system remain poorly understood. In this study, we investigate cytoprotective properties of molybdenum disulfide (MoS(2)) and molybdenum diselenide (MoSe(2)) NFs on macrophages, microglia, and dendritic cells exposed to α-Syn fibrils. We found that MoSe(2) NFs exerted strong cytoprotective properties fully mitigating toxic effects of α-Syn fibrils, while MoS(2) NFs were found to be significantly less potent in rescuing immune cells from α-Syn aggregates. At the same time, MoS(2) NFs triggered polarization of macrophages into M1 and dendritic cells into M2 phenotypes, while an increase in both M1 and M2 was observed in microglia exposed to MoS(2) NFs. MoSe(2) NFs did not trigger polarization of DC cells and microglia in M1/M2 phenotypes, while MoSe(2) NFs-facilitated polarization of macrophages into M1 was observed. These results indicate that TMD NFs could be used to improve viability of immune cells and attenuate their phenotypes, which, ultimately, can be used to treat PD and other neurodegenerative pathologies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。